Lemierre's disease caused by co-infection of Arcanobacterium haemolytic and Fusobacterium necrophorum: A case report

Journal of Infection

Volumn 45, Issue 2, 2002, Pages 114-117

  Younus, F ^a   Chua, A ^b   Tortora, G ^b   Jimenez, V E ^b  

^a Franklin Square Hospital Center   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARCANOBACTERIUM; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; FUSOBACTERIUM NECROPHORUM; HUMAN; LEMIERRE SYNDROME; MALE; MIXED INFECTION; NONHUMAN; RASH; TREATMENT FAILURE;

EID: 0036705964     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.1024     Document Type: Article

References (14)

1. Lemierre A. On certain septicemias due to anaerobic organisms. Lancet 1936; 701-703.
2. Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis 2000; 31(2): 524-532.
3. Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore) 1989; 68(2): 85-94.
4. Skov RL, Sanden AK, Danchell VH, Robertsen K, Ejlertsen T. Systemic and deep-seated infections caused by Arcanobacterium haemolyticum. Eur J Clin Microbiol Infect Dis 1998; 17(8): 578-582.
5. Ford JG, Yeatts RP, Givner LB. Orbital cellulitis, subperiosteal abscess, sinusitis, and septicemia caused by Arcanobacterium haemolyticum. Am J Ophthalmol 1995; 120(2): 261-262.
6. Washington JA, Martin WJ, Spiekerman RE. Brain abscess with Cornynebacterium hemolyticum: report of a case. Am J Clin Pathol 1971; 56(2): 212-215.
7. Hagelskjaer LH, Prag J, Malczynski J, Kristensen JH. Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990-1995. Eur J Clin Microbiol Infect Dis 1998; 17(8): 561-565.
8. Givner LB, McGehee D, Taber LH, Stein F, Sumaya CV. Sinusitis, orbital cellulitis and polymicrobial bacteremia in a patient with primary Epstein-Barr virus infection. Pediatr Infect Dis 1984; 3(3): 254-256.
9. Mackenzie A, Fuite LA, Chan FT, King J, Allen U, MacDonald N, Diaz-Mitoma F. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis 1995; 21 (1): 177-181.
10. Carlson P, Kontiainen S, Renkonen OV. Antimicrobial susceptibility of Arcanobacterium haemolyticum. Antimicrob Agents Chemother 1994; 38(1): 142-143.
11. Waagner DC. Arcanobacterium haemolyticum: biology of the organism and diseases in man. Pediatr Infect Dis J 1991; 10(12): 933-939.
12. Osterlund A. Are penicillin treatment failures in Arcanobacterium haemolyticum pharyngotonsillitis caused by intracellularly residing bacteria? Scand J Infect Dis 1995; 27(2): 131-134.
13. Alos JI, Barros C, Gomez-Garces JL. Endocarditis caused by Arcanobacterium hemolyticum. Eur J Clin Micro Inf Dis 1995; 14: 1085-1088.
14. Nyman M, Banck G, Thore M. Penicillin tolerance in Arcanobacterium haemolyticum. J Infect Dis 1990; 161(2): 261-265.